Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage

Launched by ENDEAVOR HEALTH · Mar 20, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how ultrasound exams can help predict the risk of excessive bleeding after delivery, known as postpartum hemorrhage. While many women experience heavy bleeding immediately after giving birth, this study is focused on identifying issues that might cause bleeding between 1.5 to 24 hours afterward. By performing ultrasound exams shortly after delivery, researchers hope to find signs that could indicate whether a woman is at risk for this type of bleeding.

To participate, women must be at least 37 weeks pregnant and planning to deliver at Endeavor Health. They should be able to speak English and be in early labor (less than 6 cm dilated without an epidural or less than 8 cm with an epidural) when they consent to join the study. If they agree to participate, researchers will collect information about their medical history and details of their delivery, along with ultrasound results. This information will help understand the connection between ultrasound findings and the risk of bleeding, ensuring better care for new mothers.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Currently pregnant and planning to deliver at Endeavor Health \>37 weeks gestational age
• • English speaking
• • Labor \<6cm dilated at time of consent without epidural
• • Labor \<8cm dilated at time of consent with epidural
• Exclusion Criteria:
• • Preterm delivery
• • Non-English speaking
• • Any conditions that impairs potential participants decision making